Filter Results:
(2,712)
Show Results For
- All HBS Web
(5,671)
- People (18)
- News (2,027)
- Research (2,712)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,994)
Show Results For
- All HBS Web
(5,671)
- People (18)
- News (2,027)
- Research (2,712)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,994)
Sort by
- January 2022 (Revised August 2022)
- Case
Hello Heart: The Next Generation of Chronic Disease Management Apps
By: Ariel D. Stern and Danielle Golan
Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details
Keywords: Health; Health Care and Treatment; Information Technology; Mobile and Wireless Technology; Analysis; Business Startups; Transition; Customer Focus and Relationships; Customer Satisfaction; Decision Making; Demographics; Design; Entrepreneurship; Venture Capital; Technological Innovation; Growth and Development Strategy; Product Launch; Product Design; Product Development; Business Strategy; Competitive Strategy; Competitive Advantage; Customization and Personalization; Business Growth and Maturation; Business Model; Strategy; Applications and Software; Health Industry; Health Industry; Israel; United States
Stern, Ariel D., and Danielle Golan. "Hello Heart: The Next Generation of Chronic Disease Management Apps." Harvard Business School Case 622-061, January 2022. (Revised August 2022.)
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- February 2009
- Teaching Note
Examining the Adoption of Drug-Eluting Stents (TN)
By: Elie Ofek and Peter Wickersham
Teaching Note for [509028]. View Details
- 25 Sep 2007
- First Look
First Look: September 25, 2007
model using data from 93 change projects conducted by clinical managers at the National Health Service in the United Kingdom. My findings suggest that social position is an important enabling condition for divergent organizational change,... View Details
Keywords: Martha Lagace
- 30 Jan 2012
- Research & Ideas
Measuring the Efficacy of the World’s Managers
WMS site also features individual policy reports for manufacturing, education, health-care, and retail organizations, providing a management benchmark for executives in any of those fields. On average, based on the evaluation tool, the... View Details
Keywords: by Carmen Nobel
- 17 Mar 2015
- Research & Ideas
Where Did My Shopping Mall Go?
For the longest time nobody thought malls would be seriously hurt by ecommerce but now we have enough evidence to believe that the tsunami is actually coming. If you are not careful about thinking through the implications, you will be... View Details
- 24 Feb 2009
- First Look
First Look: February 24, 2009
Authors:Daniel R. Wong, Imtiaz S. Ali, David F. Torchiana, Arvind K. Agnihotri, Richard M. J. Bohmer, and Thomas J. Vander Salm Periodical:Surgery 145, no. 2 (February 2009): 131-137 Abstract Background: Few studies of learning in the View Details
Keywords: Martha Lagace
- March 2023 (Revised March 2024)
- Case
The Purdue Pharma Bankruptcy: Settling the Opioid Crisis
By: Kristin Mugford, Carin-Isabel Knoop and Susan Pinckney
How to get to a fair outcome for claimants in the Purdue Pharma bankruptcy given its significant role in the U.S. opioid crisis. View Details
Keywords: Regulation; Ethics; Fairness; Insolvency and Bankruptcy; Government Legislation; Courts and Trials; Laws and Statutes; Lawsuits and Litigation; Legal Liability; Crime and Corruption; Negotiation Offer; Negotiation Participants; Negotiation Style; Product Design; Product Development; Brands and Branding; Marketing Strategy; Trust; Government and Politics; Law; Negotiation; Operations; Ownership; Marketing; Social Psychology; Health Care and Treatment; Pharmaceutical Industry; United States
Mugford, Kristin, Carin-Isabel Knoop, and Susan Pinckney. "The Purdue Pharma Bankruptcy: Settling the Opioid Crisis." Harvard Business School Case 223-060, March 2023. (Revised March 2024.)
- November 2020
- Supplement
Improving Access at VA (Update)
By: Ryan W. Buell
In November 2020, Chief Veterans Experience Officer, Lynda Davis, and Deputy Chief Veterans Experience Officer, Barbara C. Morton reflect on a busy four years leading the Veterans Experience Office at the U.S. Department of Veterans Affairs. The case provides an update... View Details
Keywords: Government; Service Management; Leading Change; Transformation; Service Operations; Management; Health Care and Treatment; Government Administration; Performance Improvement; Public Administration Industry; United States
Buell, Ryan W. "Improving Access at VA (Update)." Harvard Business School Supplement 621-070, November 2020.
- January 2014 (Revised June 2014)
- Supplement
23andMe: Genetic Testing for Consumers (B)
By: John A. Quelch and Margaret L. Rodriguez
Following the FDA's letter in November 2013, which ordered 23andMe to cease sales of its DNA test kits, observers wondered how co-founder and CEO, Anne Wojcicki, would guide the company in the presence of uncertainty. View Details
Keywords: Risk and Uncertainty; Genetics; Crisis Management; Health Care and Treatment; Product Development; Business and Government Relations; Biotechnology Industry; Consumer Products Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (B)." Harvard Business School Supplement 514-095, January 2014. (Revised June 2014.)
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
An online shipping platform that uses social networks and smartphones. Low-cost medical care and monitoring that helps seniors to live at home. The "Skype" of broadband, offering free Internet service. On an April morning known as "Super... View Details
- 29 Jun 2007
- First Look
First Look: June 29, 2007
seemed the government's Black Economic Empowerment (BEE) policies were only enriching a few. In 1997, Surve and three of his comrades founded Sekunjalo, an investment holding company that sought to offer "a gentler capitalism"... View Details
Keywords: Martha Lagace
- 22 Jun 2021
- Research & Ideas
The COVID-19 Mutiny: When Teams Leave and Take Their Clients
the team. Have key technical skills so you can advise the team. Collaborate across the company. And finally, be a strong decision maker. Plant the greener pastures. Ensure that high-revenue employees have options within the company for “intrapreneurial” activities,... View Details
- 14 Jan 2014
- First Look
First Look: January 14
treated and discharged at a faster rate in the dedicated queuing system than in the pooled queuing system. We conduct additional analyses to rule out alternate explanations, such as stinting on care and decreased quality of care. Our... View Details
Keywords: Sean Silverthorne
- 15 May 2018
- First Look
New Research and Ideas, May 15, 2018
School Case 317-073 Prevent Senior: A New Paradigm for Growth in the Health Care Sector? No abstract available. Purchase this case:https://cb.hbsp.harvard.edu/cbmp/product/317073 Harvard Business School Case... View Details
Keywords: Dina Gerdeman
- 02 Jun 2011
- What Do You Think?
Is it Time for a National Bankruptcy?
involved a developed economy, "That would (suggest) a new type of fourth world country, a developed economy which just turned into a developing one." Should world financial policy essentially reflect a philosophy of "let... View Details
Keywords: by Jim Heskett
- 19 Dec 2017
- First Look
New Research and Ideas, December 19, 2017
is likely to have a meaningful effect on health care spending patterns. In addition, precision medicines can change the expected profitability of therapies both by allowing more sophisticated pricing systems... View Details
Keywords: Carmen Nobel
- April 2012
- Case
Bella Healthcare India
By: Dorothy Leonard and Sunru Yong
Bella Healthcare India was originally established in Bangalore as a low-cost manufacturing facility for a U.S.-based cardiology equipment developer. Under country manager Joseph Cherian it evolved considerably, developing its own research and development capabilities.... View Details
Keywords: India; Productivity; Organizational Development; International Business; R＆D; Cross-cultural Relations; Medical Equipment ＆ Devices; Joint Ventures; Medical Specialties; Research and Development; Product Development; Organizational Change and Adaptation; Strategy; Decision Choices and Conditions; Health Care and Treatment; Product Launch; Failure; Cross-Cultural and Cross-Border Issues; Medical Devices and Supplies Industry; Bangalore
Leonard, Dorothy, and Sunru Yong. "Bella Healthcare India." Harvard Business School Brief Case 124-440, April 2012.
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
forthcoming American Economic Journal: Economic Policy Selection and Market Reallocation: Productivity Gains from Multinational Production By: Alfaro, Laura, and Maggie X. Chen Abstract—Assessing the productivity gains from multinational... View Details
Keywords: Sean Silverthorne
- 12 Feb 2014
- Research & Ideas
Private Sector, Public Good
was to make a series of unsustainable promises that sustained the illusion of prosperity" by extending easy credit to fuel consumption, covering health care and retirement costs, and directly employing... View Details
Keywords: by Dina Gerdeman